BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 22652826)

  • 1. Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications.
    Arnaldi G; Mancini T; Tirabassi G; Trementino L; Boscaro M
    J Endocrinol Invest; 2012 Apr; 35(4):434-48. PubMed ID: 22652826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercortisolism in obesity-associated hypertension.
    Varughese AG; Nimkevych O; Uwaifo GI
    Curr Hypertens Rep; 2014 Jul; 16(7):443. PubMed ID: 24801134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension in Cushing's syndrome.
    Magiakou MA; Smyrnaki P; Chrousos GP
    Best Pract Res Clin Endocrinol Metab; 2006 Sep; 20(3):467-82. PubMed ID: 16980206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cushing syndrome: When to suspect and how to confirm?].
    Guignat L; Bertherat J
    Presse Med; 2014 Apr; 43(4 Pt 1):366-75. PubMed ID: 24656297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes in Cushing syndrome: basic and clinical aspects.
    Mazziotti G; Gazzaruso C; Giustina A
    Trends Endocrinol Metab; 2011 Dec; 22(12):499-506. PubMed ID: 21993190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical consequences of Cushing's syndrome.
    Valassi E; Crespo I; Santos A; Webb SM
    Pituitary; 2012 Sep; 15(3):319-29. PubMed ID: 22527617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic disorders during endogenous Cushing's syndrome: prevalence, associated factors, and outcome after remission.
    Chihaoui M; Oueslati I; Khessairi N; Chaker F; Cherni S; Hammami B; Feki M; Yazidi M
    Endocr Regul; 2023 Jan; 57(1):138-143. PubMed ID: 37561832
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors predicting long-term comorbidities in patients with Cushing's syndrome in remission.
    Schernthaner-Reiter MH; Siess C; Gessl A; Scheuba C; Wolfsberger S; Riss P; Knosp E; Luger A; Vila G
    Endocrine; 2019 Apr; 64(1):157-168. PubMed ID: 30467627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surviving ectopic Cushing's syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up.
    Osswald A; Deutschbein T; Berr CM; Plomer E; Mickisch A; Ritzel K; Schopohl J; Beuschlein F; Fassnacht M; Hahner S; Reincke M
    Eur J Endocrinol; 2018 Aug; 179(2):109-116. PubMed ID: 29875286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular risks and their long-term clinical outcome in patients with subclinical Cushing's syndrome.
    Tsuiki M; Tanabe A; Takagi S; Naruse M; Takano K
    Endocr J; 2008 Aug; 55(4):737-45. PubMed ID: 18506093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines.
    Mancini T; Kola B; Mantero F; Boscaro M; Arnaldi G
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):768-77. PubMed ID: 15579193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular disease in Cushing's syndrome: heart versus vasculature.
    De Leo M; Pivonello R; Auriemma RS; Cozzolino A; Vitale P; Simeoli C; De Martino MC; Lombardi G; Colao A
    Neuroendocrinology; 2010; 92 Suppl 1():50-4. PubMed ID: 20829618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cushing's syndrome: update on signs, symptoms and biochemical screening.
    Nieman LK
    Eur J Endocrinol; 2015 Oct; 173(4):M33-8. PubMed ID: 26156970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of COVID-19 in Cushing's disease is independently related to disease activity (hypercortisolism) and obesity.
    M G Mascarenhas-Nakano B; R Correa-Silva S; Fracacio SMR; W Brock P; F Dias R; Binda ESS; Santos-Neto PF; Portari LHC; Sanudo A; Abucham J
    Arch Endocrinol Metab; 2024 Mar; 68():e220313. PubMed ID: 38557479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of atherosclerosis in patients with Cushing's syndrome: a meta-analysis of literature studies.
    Lupoli R; Ambrosino P; Tortora A; Barba L; Lupoli GA; Di Minno MN
    Ann Med; 2017 May; 49(3):206-216. PubMed ID: 27763781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid excess and COVID-19 disease.
    Guarnotta V; Ferrigno R; Martino M; Barbot M; Isidori AM; Scaroni C; Ferrante A; Arnaldi G; Pivonello R; Giordano C
    Rev Endocr Metab Disord; 2021 Dec; 22(4):703-714. PubMed ID: 33025384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cushing's syndrome].
    Guignat L; Bertagna X; Bertherat J
    Rev Prat; 2008 May; 58(9):957-65. PubMed ID: 18672661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Telomeres, aging and Cushing's syndrome: are they related?].
    Aulinas A; Santos A; Valassi E; Mato E; Crespo I; Resmini E; Roig O; Bell O; Webb SM
    Endocrinol Nutr; 2013; 60(6):329-35. PubMed ID: 23218933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cushing's Syndrome: Where and How to Find It.
    Debono M; Newell-Price JD
    Front Horm Res; 2016; 46():15-27. PubMed ID: 27211887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cushing's Syndrome Effects on the Thyroid.
    Paragliola RM; Corsello A; Papi G; Pontecorvi A; Corsello SM
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.